Prospective Clinical Trial of Mycophenolate Mofetil (MMF) De-Escalation in Allogeneic Hematopoietic Cell Transplantation (HCT) for Primary Immunodeficiency (PID): MMF Is Dispensable in Reduced-Intensity Conditioning, Posttransplantation Cyclophosphamide(PTCy)-Based HCT

Authors :: Dimana Dimitrova
Scott Napier
Jennifer Sponaugle
Anita Stokes
Mustafa Hyder
Gulbu Uzel
Luigi D. Notarangelo
Alexandra F. Freeman
Jenna R.E. Bergerson
Steven M. Holland
Mark Roschewski
Christopher Melani
Jeffrey I. Cohen
Andrea Lisco
Irini Sereti
Christa Zerbe
Amanda K. Ombrello
Deborah Stone
Jennifer Cuellar-Rodriguez
Juan Gea-Banacloche
Mark Parta
Jennifer Wilder
Amy Chai
Daniel H. Fowler
Ronald E Gress
Christopher G. Kanakry
Jennifer A. Kanakry
Source :: Transplantation and Cellular Therapy. 28:S14-S16
Publication Year :: 2022
Publisher :: Elsevier BV, 2022.

Subjects :: Transplantation
Molecular Medicine
Immunology and Allergy
Cell Biology
Hematology

Full Text Access

Tools